Retigabine (Q36697501)

15 August 2017

1 reference

title

Retigabine. (English)

1 reference

15 August 2017

Roger J Porter

1

1 reference

15 August 2017

Virinder Nohria

series ordinal

2

1 reference

15 August 2017

Chris Rundfeldt

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

149-154

1 reference

New visions in the pharmacology of anticonvulsion

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Synthesis and quantitative structure-activity relationships of anticonvulsant 2,3,6-triaminopyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Clinical aspects of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by 4-aminopyridine in rat entorhinal cortex hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Effects of retigabine on rhythmic synchronous activity of human neocortical slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

The new anticonvulsant retigabine (D-23129) acts as an opener of K channels in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

A potassium channel mutation in neonatal human epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K channels causes epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

The therapeutic potential of neuronal KCNQ channel modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

KCNQ4, a K channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.NURT.2006.11.012

General pharmacologic studies on the analgesic flupirtine

21 January 2018

1 reference

12 December 2020

Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels.

1 reference

12 December 2020

Antiepileptic drug development program: a cooperative effort of government and industry

1 reference

12 December 2020

Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response

1 reference

12 December 2020

Characterization of the K channel opening effect of the anticonvulsant retigabine in PC12 cells

1 reference

12 December 2020

10.1016/J.NURT.2006.11.012

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1047330083

0 references

1 reference